Stay updated with breaking news from Simona Camero. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evgen Pharma PLC (AIM:EVG) said its collaborative research with Sapienza University of Rome has confirmed the potential of lead asset SFX-01 to augment the...
(Alliance News) - Evgen Pharma PLC on Tuesday said its lead asset SFX-01 has radio-sensitising effects in vivo in a form of soft tissue sarcoma, as part of its research partnership with Sapienza University of Rome. The Cheshire, England-based clinical s...
Investegate announcements from Evgen Pharma PLC, Further evidence of radiosensitisation by SFX-01